Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

European researchers launch 10 million Euro collaborative technology project

12.02.2004


European researchers launch 10 million Euro collaborative technology project: EMBL-Hamburg coordinates a four-year integrated research project within the 6th Framework Programme of the European Commission:



The European Commission has given Europe a huge boost in the field of Structural Genomics, awarding the European Molecular Biology Laboratory (EMBL) and its partners 10 Million Euro for an integrated project called “BIOXHIT.” The project aims to create a common platform throughout Europe for researchers working in the field of “biological crystallography.”

BIOXHIT stands for “Biocrystallography on a Highly Integrated Technology Platform” for European Structural Genomics. The goal is to take the best of current technologies at major European centres for research in structural biology, develop them further and weave them into a single platform that integrates and standardises the best of current technology, and spread it throughout Europe.


EMBL-Hamburg will coordinate the integrated project, which unites over twenty partners from nine European countries, including all European synchrotrons. BIOXHIT combines a strongly focused research programme with networking, training and mobility of staff under a single and efficient management structure.

Biological crystallography aims to create precise, three-dimensional “architectural” models of biological molecules. Without such models at hand, it is close to impossible to understand biological processes, for instance the way proteins and other molecules behave in cells, or to design new drugs that will affect their functions. The most common method for obtaining such three-dimensional models is to bombard crystallised proteins with high-powered X-rays generated at huge synchrotron facilities.

“We already have all the single components necessary to solve molecular structures,” says Victor Lamzin, grant coordinator at EMBL-Hamburg. “We have synchrotrons, we can grow protein crystals, we have the software components and we can obtain structures. But the tools we use were not originally designed for high-throughput work. This is what is needed now because of the tens of thousands of new molecules we have discovered in the many genome sequencing projects. Each step of three-dimensional analysis is at a different state at each facility. With this major grant, the Commission strives to support the development and the integration of the best technology at each step, and then spread that across all of the sites.”

Several new European synchrotrons, now on the drawing board or under construction, are scheduled to go on line by 2006 or 2007. BIOXHIT calls for them to begin using the platform from their first day of operations.

One immediate effect of BIOXHIT will be a significant reduction in the time involved in obtaining each structure. Robots, for example, can perform tasks automatically, quickly, and at a consistent and high precision, replacing time-consuming manual steps. The project specifically calls for improvements in the process by which samples are handled, the equipment needed to detect X-ray patterns, and the computers and software needed to model structures. A result of this will be to attract more researchers to work on protein structures.

“Biocrystallography used to be a field for specialists,” Lamzin says, “but today, researchers from all walks of biology want to solve molecular structures at the synchrotrons. The new platform will make this process very user-friendly; it will even allow them to send us their samples and work remotely, from their own institutions.”

“This grant from the EC will definitely make Europe a substantial player in this area,” Lamzin notes. “As well as uniting technologies, BIOXHIT will unite other European and national activities into one strong European alliance, giving us the strength to be a major competitor in Structural Genomics on a global scale. Similar initiatives are already underway in the US and Japan, our two main competitors in this area.”

Training activities are a cornerstone of the project. A number of Training, Implementation and Dissemination centres will be created outside the participating laboratories to disseminate the know-how. A proactive training effort will take place at synchrotron facilities, and then be spread to satellite centres to disseminate biocrystallography technologies to local European communities.

Trista Dawson | EMBL
Further information:
http://www.embl-heidelberg.de/ExternalInfo/oipa/pr2004/pr120204.pdf

More articles from Life Sciences:

nachricht Mass spectrometry sheds new light on thallium poisoning cold case
14.12.2018 | University of Maryland

nachricht Protein involved in nematode stress response identified
14.12.2018 | University of Illinois College of Agricultural, Consumer and Environmental Sciences

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Data use draining your battery? Tiny device to speed up memory while also saving power

14.12.2018 | Power and Electrical Engineering

Tangled magnetic fields power cosmic particle accelerators

14.12.2018 | Physics and Astronomy

In search of missing worlds, Hubble finds a fast evaporating exoplanet

14.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>